Ir al contenido
Buscar Cesta Solicitar presupuesto

Cesta

La cesta está vacía

Tissue Paper Factory Feasibility Study

Tissue Paper Factory Feasibility Study

Explore las últimas noticias, información sobre productos y actualizaciones de la industria de rolangear, su fuente de líneas de producción y soluciones de maquinaria avanzadas.

Artículo: Tissue Paper Factory Feasibility Study

Tissue Paper Factory Feasibility Study

Industrial Feasibility Study

Tissue Paper Factory Feasibility Study

Professional feasibility study for a small-to-medium tissue paper converting factory producing facial tissue, toilet rolls, napkins, kitchen towels and private-label tissue packs. Because no country, city, raw-material price, utility tariff, building condition or supplier quotation was supplied, this report uses transparent USD planning assumptions that must be localized before investment approval.

Project investment
$1.43m
Saleable capacity
1,440 t/y
Base NPV / IRR
$61,378 / 13.5%
Break-even utilization
39.6%

Study Map

  1. Executive summary
  2. Product analysis
  3. Machinery and equipment
  4. Investment costs
  5. Financial statements
  6. Sensitivity analysis
  7. Sources and assumptions

1. Executive Summary

The project is a tissue paper converting factory that purchases jumbo tissue parent rolls and converts them into facial tissue boxes, toilet paper rolls, napkins, kitchen towels and private-label tissue packs. The base case assumes 600 kg/hour rated converting output, 80% operating efficiency, 10 hours/day, 300 operating days/year and 100% saleable planning yield after normal waste recovery, giving 1,440 tons/year of saleable finished tissue products.

Using a blended ex-factory selling price of USD 2,500/ton, variable cost of USD 1,650/ton and total investment of $1.43m, Year-5 revenue reaches $3.24m and Year-5 net profit reaches $444,778. Base NPV is $61,378 at a 12% discount rate, estimated IRR is 13.5%, and break-even utilization is 39.6%.6%.

Preliminary verdict: the project is financially positive under the stated budgetary assumptions, but final approval depends on local jumbo-roll cost, packaging cost, retail/distributor contracts, building hygiene, energy reliability and confirmed machinery quotations.

2. Study Scope and Methodology

This study covers the full investment-report scope: market, technical, operating, staffing, investment, financing, revenue, financial statements, indicators, break-even, sensitivity, legal, EHS, risk, implementation, sources, consultation and final recommendation. World Bank indicators support macro and demand-localization context [1][2]. HS Chapter 48 supports paper/tissue trade classification caveats [3]. ISO tissue-paper standards, EPA pulp-and-paper context, OSHA paper-machine guarding guidance and EU waste policy provide standards, environmental and safety references [4][5][6][7].

Important limitation: no target country, city, tax regime, utility tariff, jumbo-roll supplier, building status or confirmed selling prices were supplied. Values are planning estimates and must be localized.

3. Project Concept and Nature

The project is a hygienic paper converting factory, not an integrated pulp-and-paper mill. The plant buys parent rolls from tissue mills or importers, then embosses, rewinds, folds, cuts, interfolds, packs and cartons finished tissue products. The business model can combine local wholesale supply, retail private label, institutional/HORECA supply and distributor sales.

4. Product Analysis and Product-Specification Table

Core product specifications include tissue grade, ply count, grammage, sheet size, roll length, embossing pattern, softness, absorbency, box or film packaging and carton count. Hygiene and product-compliance claims should not be made until raw material, production conditions and local standards are verified.

Product specification table
Product Typical specification Target channel Quality notes
Facial tissue boxes 2-ply, 100–200 sheets/box Retail, offices, hotels Softness, dust control, box strength
Toilet paper rolls 1–3 ply, multiple roll lengths Retail and distributors Sheet strength, perforation, winding firmness
Napkins 1–2 ply, quarter or dispenser fold Restaurants, cafés, catering Fold accuracy and pack count
Kitchen towels 2-ply absorbent rolls Retail and households Absorbency and roll consistency
Private-label tissue packs Buyer-specific packs and cartons Supermarkets and distributors Artwork, barcode, carton and QC approval

5. Economic Indicators and Project Location

Tissue demand is linked to population, household income, retail development, tourism, hotels, restaurants, schools, healthcare and workplace consumption. World Bank population and manufacturing indicators should be used when localizing the study [1][2]. Location should prioritize clean industrial zoning, access to jumbo rolls and packaging suppliers, retail distribution routes, power reliability and hygienic storage space.

Weighted project-location matrix
Factor Weight Preferred condition Effect
Jumbo-roll supply and logistics 24% Near paper mills, importers or ports Controls raw-material cost and stock risk
Clean industrial building 18% Dust-controlled, dry and pest-controlled space Protects hygiene and quality
Customer route density 17% Near retailers, wholesalers, hotels and institutions Improves delivery economics
Electricity and compressed air 14% Reliable power for converting and packing Protects uptime
Packaging suppliers 11% Cartons, film, boxes and labels available Reduces stockouts
Labor availability 9% Operators, packers and maintenance staff Supports output quality
Regulatory clarity 7% Clear labeling, hygiene and waste rules Reduces launch delays

6. Target-Market Indicators with TAM, SAM and Realistically Obtainable Market Separation

TAM, SAM and obtainable market separation
Layer Definition Planning treatment
TAM All facial tissue, toilet rolls, napkins, kitchen towels and institutional tissue demand Not fully available to one project
SAM Demand reachable through planned retailers, distributors and HORECA/institutional customers Requires local distributor validation
Realistically obtainable market Volume a new converter can win within five years Limited by brand trust, shelf access and credit terms
Project sales forecast Ramp-up to 1,296 t/y by Year 5 Capacity-led forecast, not a market-share claim

7. Demand Analysis

Because no country was supplied, the study uses a capacity-led forecast rather than a national consumption forecast. Formula: 600 kg/hour × 80% efficiency × 10 hours/day × 300 days/year = 1,440 tons/year saleable output. Year-1 sales = 720 tons; Year-5 sales = 1,296 tons. For localization, demand should be calculated using population × annual tissue consumption per person, plus institutional customer counts, apparent consumption and retailer/distributor interviews.

8. Local Production Analysis

Local production analysis should identify integrated tissue mills, parent-roll importers, small converting factories, napkin converters, private-label suppliers, supermarket brands and imported finished tissue. Exact local production is not stated because no country was provided; it should be verified through industrial registries, customs data, distributor interviews and store shelf checks.

9. Import and Export Analysis with HS-Code Caveats

Likely product classifications fall under HS Chapter 48 for paper and paperboard articles. Tissue-related finished goods may be classified under headings such as HS 4818 for toilet paper and similar household or sanitary paper articles, while parent rolls may fall under different paper headings depending on format and national tariff detail [3]. These HS codes can be broad, so trade data must not be treated as exact facial tissue or toilet-roll demand without subheading validation.

10. Competitor Analysis

Competitor analysis table
Competitor type Examples to research locally Pressure Response
Integrated tissue mills Mills with converting and brands High Compete through service, private label and flexible SKUs
Small converters Local napkin/facial tissue workshops Medium-high Improve hygiene, pack quality and delivery
Imported finished tissue Regional brands and importers Medium Use faster delivery and local pack customization
Private-label suppliers Converters serving supermarkets High for retail shelves Offer reliable specification and packaging approval
Substitutes Cloth towels, hand dryers in institutions Low-medium Focus on hygiene and convenience

11. Market-Gap Analysis

Market gap should be calculated as total tissue demand plus import-replacement potential minus reliable local production, adjusted for brand loyalty and shelf access. In the base model, the factory needs to sell 1,296 tons by Year 5. This must be supported by distributor agreements, supermarket listing discussions and HORECA/institutional customer interviews before final approval.

12. SWOT Analysis

SWOT analysis
Strengths Weaknesses Opportunities Threats
Daily-use hygiene product with broad demand Brand trust and shelf access take time Private label, HORECA and institutional supply Jumbo-roll price volatility
Moderate converting technology compared with paper milling Packaging design and QC affect repeat sales Multiple product formats from shared equipment Strong existing brands and promotions
Scalable SKU mix Requires clean storage and dust control Local customization and short lead times Currency and import-cost exposure

13. Marketing and Promotional Plan

The marketing plan should focus on distributor onboarding, retail sampling, HORECA/institutional trial packs, private-label proposals, packaging design, consistent pack count and reliable delivery. KPIs include repeat order rate, active outlets, retailer returns, complaint rate, production waste, margin by SKU, delivery fill rate and receivable days.

14. Pricing Plan

Pricing plan table, USD per ton finished tissue
Product Planning selling price Pricing logic
Facial tissue boxes USD 2,200–2,700/t Box, ply, sheet count and softness affect price
Toilet paper rolls USD 1,900–2,400/t Roll length, ply and bundle format drive price
Napkins USD 2,000–2,500/t Fold, embossing and food-service pack size matter
Kitchen towels USD 2,200–2,800/t Absorbency and roll size support premium pricing
Blended model price USD 2,500/t Used for base financial model

15. Distribution Plan

Distribution should combine wholesale distributors, supermarkets, mini-markets, hotels, restaurants, offices, healthcare/institutional buyers and selected private-label customers. Retail products need packaging, barcode and shelf-display discipline; institutional products need carton strength, volume pricing and delivery reliability.

16. Machinery, Equipment, and Production-Line Costs

RGT-B30 Automatic Facial Tissue Bundle Packing Machine

Machinery costs are budgetary planning estimates, not supplier quotations. Final cost depends on facial tissue interfold type, toilet roll rewinder speed, napkin folder capacity, automatic packing level, embossing, printing, carton packing, voltage, installation and destination.

Machinery table and production-line cost components
Machine/equipment Function Budgetary estimate
Facial tissue interfolding line Folds, counts and cuts facial tissue USD 120k–260k
Toilet roll rewinder and log saw Rewinds parent rolls and cuts finished rolls USD 130k–280k
Napkin folding machine Folds and embosses napkins USD 50k–140k
Kitchen towel rewinding option Produces absorbent towel rolls USD 60k–150k
Automatic packing/bundling machines Film, box, bundle and carton packing USD 150k–350k
Compressor, vacuum, dust control and electrical Factory support utilities USD 70k–160k
QC tools and handling equipment GSM, weight, count and warehouse control USD 20k–60k

17. Building, Facility, and Construction Costs

The facility should include parent-roll storage, converting hall, packing area, finished-goods warehouse, packaging-material store, dust collection, QC room, maintenance area, staff hygiene area, office and dispatch bay. The base model assumes an existing leased or owned building requiring hygiene fit-out, dust control, electrical distribution, compressed air and warehouse racking.

18. Production Capacity and Line Suitability

Rated output is modeled at 600 kg/hour. Effective output = 600 × 80% = 480 kg/hour. Daily output = 480 × 10 hours = 4.8 tons/day. Annual output = 4.8 × 300 days = 1,440 tons/year. Bottlenecks may occur in parent-roll changeover, folding speed, log-saw cutting, packaging speed, carton availability, dust control and finished-goods storage.

19. Supplier Quotations and Technical Offers

No supplier quotation was provided. Final technical offers should confirm parent-roll width, grammage range, ply compatibility, embossing pattern, folding style, output speed by SKU, packing format, carton pack arrangement, power and compressed-air needs, spare parts, warranty, installation, training and Incoterm.

20. Raw-Material Costs

Main inputs are jumbo tissue parent rolls, cores, cartons, plastic film, printed boxes, labels, glue, inks where used, tape and pallets. The base variable cost is USD 1,650/ton finished tissue, including parent rolls, packaging, direct labor, utilities and normal waste. Parent-roll cost is the largest variable-cost driver.

21. Operating Requirements and Expenses

Annual fixed operating expenses are estimated at $360,000 in Year 1 before depreciation, increasing 3% annually. This covers management, supervisors, QA, maintenance, sales/admin, insurance, security, cleaning, basic marketing, pest control and non-variable overhead.

22. Utility Requirements

Utility requirements table
Utility Requirement to confirm Effect
Electricity 3-phase power for rewinders, folders, packing and conveyors Controls uptime
Compressed air Packing, cutting and machine actuators Conversion reliability
Dust extraction Tissue dust collection and housekeeping Quality and safety
Vacuum system Some folding and transfer operations Line stability
Water and sanitation Cleaning and staff hygiene Food/hygiene buyer acceptance
Fire safety Alarms, extinguishers and paper storage separation High because tissue is combustible

23. Organizational and Management Structure

Staffing table
Role Headcount Main responsibility
General manager 1 Operations, sales and finance
Production supervisor 2 Shift output, quality and waste
Machine operators 8 Interfolding, rewinding, napkin and packing lines
Packing operators 12 Boxing, bundling, carton packing and palletizing
Quality-control technician 2 GSM, count, pack, dust and release checks
Maintenance/electrician 3 Mechanical, electrical and compressed air support
Warehouse/dispatch 4 Parent rolls, finished goods and loading
Sales/admin/accounting 4 Orders, invoices, credit and customer service

24. Investment Costs

Capital investment estimate, USD
Investment item Estimate Basis
Facial tissue, toilet roll and napkin converting lines $520,000 Budgetary equipment package
Automatic packing, bundling and carton support $190,000 Packaging automation allowance
Electrical, compressed air, dust control and utilities $150,000 Utility allowance
Building hygiene fit-out, warehouse racking and fire safety $110,000 Existing-building allowance
QC, workshop, handling and IT tools $100,000 Support equipment
Freight, installation, training and commissioning $90,000 Destination-dependent allowance
Pre-operating expenses, permits and launch $45,000 Planning estimate
Contingency reserve $45,000 Approximate reserve
Initial working capital $180,000 Parent rolls, packaging and receivables
Total project investment $1.43m Calculated subtotal

25. Financing Requirements and Conditions

Base financing assumes 40% equity and 60% debt. Equity requirement is $572,000 and loan requirement is $858,000. Loan terms are modeled at 9% annual interest, five-year equal principal repayment and no grace period. Final terms depend on lender, collateral, country risk and confirmed investment scope.

26. Revenue and Sales Forecasts

Base-case sales and profitability forecast
Year Utilization Sales volume, tons Revenue Gross profit EBITDA Net profit DSCR
Y1 50.0% 720 $1.80m $612,000 $252,000 $39,824 0.97x
Y2 65.0% 936 $2.34m $795,600 $424,800 $190,419 1.62x
Y3 75.0% 1,080 $2.70m $918,000 $536,076 $291,795 2.13x
Y4 85.0% 1,224 $3.06m $1.04m $647,018 $392,904 2.71x
Y5 90.0% 1,296 $3.24m $1.10m $696,417 $444,778 3.13x
Scenario comparison
Scenario Key assumptions Y5 sales Y5 revenue Interpretation
Conservative 70% utilization; price -6%; parent roll +5% 1,008 t/y $2.18m Marginal; needs contracts and cost control
Base case 90% utilization; USD 2,500/t price 1,296 t/y $3.24m Positive under assumptions
Optimistic 95% utilization; price +5%; strong private label 1,368 t/y $3.30m Strong if shelf access is secured

27. Financial Statements

Projected income statement, USD
Year Utilization Sales volume Revenue Gross profit EBITDA Net profit DSCR
Y1 50.0% 720 $1.80m $612,000 $252,000 $39,824 0.97x
Y2 65.0% 936 $2.34m $795,600 $424,800 $190,419 1.62x
Y3 75.0% 1,080 $2.70m $918,000 $536,076 $291,795 2.13x
Y4 85.0% 1,224 $3.06m $1.04m $647,018 $392,904 2.71x
Y5 90.0% 1,296 $3.24m $1.10m $696,417 $444,778 3.13x
Cash-flow statement summary, USD
Year Operating cash flow Debt principal repayment Levered cash flow Cumulative equity cash flow Closing debt
Y1 $164,824 $171,600 $-6,776 $-578,776 $686,400
Y2 $315,419 $171,600 $143,819 $-434,957 $514,800
Y3 $416,795 $171,600 $245,195 $-189,762 $343,200
Y4 $517,904 $171,600 $346,304 $156,543 $171,600
Y5 $569,778 $171,600 $398,178 $554,721 $0
Statement of financial position summary, USD
Year Net fixed assets Inventory Receivables Cash Total assets Payables Loan balance Equity + retained earnings Liabilities + equity
Y1 $1.12m $97,644 $197,260 $-40,310 $1.38m $81,370 $686,400 $611,824 $1.38m
Y2 $1.00m $126,937 $256,438 $39,449 $1.42m $105,781 $514,800 $802,243 $1.42m
Y3 $875,000 $146,466 $295,890 $241,937 $1.56m $122,055 $343,200 $1.09m $1.56m
Y4 $750,000 $165,995 $335,342 $545,534 $1.80m $138,329 $171,600 $1.49m $1.80m
Y5 $625,000 $175,759 $355,068 $922,359 $2.08m $146,466 $0 $1.93m $2.08m

28. Financial Indicators and Financial Analysis

Financial indicators and financial ratios
Indicator Formula / basis Base result Interpretation
Gross margin Revenue minus COGS divided by revenue 34.0% Healthy if parent-roll cost is controlled
Contribution margin Selling price minus variable cost USD 850/ton Used for break-even
Break-even quantity Fixed cost + depreciation divided by contribution 571 tons/year Requires 39.6% utilization
ROI Average net profit divided by investment 19.0% Positive after ramp-up
NPV Unlevered cash flow discounted at 12% $61,378 Positive but sensitive to selling price and parent-roll cost
IRR Discount rate where NPV equals zero 13.5% Above the 12% hurdle rate
Payback Cumulative levered equity cash recovery During Year 4 Depends on working capital
Debt-to-equity Debt divided by equity 1.50x Moderate leverage
Minimum cash requirement Initial working capital $180,000 Needed for jumbo rolls and receivables

29. Break-Even Analysis

Contribution per ton = 2,500 − 1,650 = 850 USD/ton. Break-even quantity = fixed cost plus depreciation ($485,000) ÷ contribution = 571 tons/year. Break-even revenue = $1.43m and break-even utilization = 39.6% of annual saleable capacity.

Break-even utilization chart
Break-even utilization chart, percent of saleable capacity 0%100%Break-even 39.6%

Source: calculated base-case model, 2026. Unit: percent of annual saleable capacity.

30. Sensitivity Analysis

Sensitivity analysis, approximate NPV impact
Variable tested NPV impact Criticality
Selling price -10% $-356,000 High
Jumbo-roll tissue cost +10% $-302,000 High
Sales utilization -10% $-188,000 High
Packaging cost +10% $-56,000 Medium
Labor +10% $-62,000 Medium
Electricity +10% $-33,000 Medium
Capital cost +10% $-143,000 Medium
Interest +2 pts $-31,000 Medium
Launch delay 6 months $-170,000 High
Selling price +10% $356,000 High
Tornado-style NPV sensitivity impact
Tornado-style NPV sensitivity impact, USD Selling price -10%$-356,000Jumbo-roll tissue cost +10%$-302,000Sales utilization -10%$-188,000Packaging cost +10%$-56,000Labor +10%$-62,000Electricity +10%$-33,000Capital cost +10%$-143,000Interest +2 pts$-31,000Launch delay 6 months$-170,000Selling price +10%$356,000

Source: calculated sensitivity model, 2026. Unit: USD impact on NPV.

Critical-variable ranking: selling price, parent-roll cost, utilization, launch delay and capital cost are the main viability drivers.

31. Legal and Regulatory Requirements

Requirements normally include company registration, industrial license, environmental approval, fire-safety approval, worker safety rules, tax registration, labeling rules, waste-management procedure and packaging rules. Tissue products may need local hygiene, labeling and product-safety review. ISO 12625 standards provide tissue-paper test and terminology references but do not replace local certification [4].

32. Environmental, Health, and Safety Analysis

EHS issues include tissue dust, fire load, machine nip points, rotating shafts, log saws, blades, compressed air, lifting of parent rolls, noise, packaging waste and housekeeping. Paper-machine guarding and safe isolation are important safety principles [6]. EPA pulp-and-paper references are more relevant to integrated mills, but converting factories still need waste, dust and fire controls [5].

33. Risk Analysis and Risk Register

Risk register
Risk Probability Impact Mitigation
Jumbo-roll price increase High High Supplier contracts and price-adjustment terms
Slow retail listing Medium High Distributor agreements and private-label trials before launch
Packaging shortage Medium Medium-high Multiple carton, film and box suppliers
High production waste Medium Medium Operator training and QC checks
Dust or fire incident Low-medium High Dust extraction, fire safety and housekeeping
Strong brand competition High Medium-high Focus on private label, institutional channels and reliable delivery
Receivable delay Medium Medium Credit limits, deposits and collection controls

34. Implementation Schedule

Implementation schedule timeline
Phase Duration Key tasks
Feasibility localization 2–4 weeks Country data, jumbo-roll prices, customer interviews and SKU plan
Engineering, permits and quotations 1–2 months Layout, permits, utilities and supplier offers
Procurement and manufacturing 2–3 months Machine order, packing format and shipment
Civil works and utilities 2–3 months Electrical, compressed air, dust control and warehouse setup
Installation and commissioning 4–6 weeks Machine installation, training and trial production
Commercial launch 1 month Sampling, distributor onboarding and first orders
Gantt-style implementation view
Implementation schedule, months 1 to 10 LocalizationPermits and offersProcurementCivil and utilitiesInstallationLaunchMonth 0Month 10

Source: implementation planning assumption, 2026. Unit: months.

Data-Driven Charts

Revenue forecast
Revenue forecast, USD million Y11.8Y22.3Y32.7Y43.1Y53.2

Source: calculated base-case model, 2026. Unit: USD million.

Net profit forecast
Net profit forecast, USD thousand Y140kY2190kY3292kY4393kY5445k

Source: calculated base-case model, 2026. Unit: USD thousand.

Capacity utilization ramp-up
Capacity utilization ramp-up, percent Y150%Y265%Y375%Y485%Y590%

Source: ramp-up assumption, 2026. Unit: percent.

Investment cost composition
Investment cost composition, USD Converting lines$520,000Packing and bundling$190,000Utilities/facility$260,000Support and QC$100,000Pre-op contingency WC$360,000

Source: investment model, 2026. Unit: USD.

Variable cost composition
Variable cost composition, percent Jumbo tissue rolls72%Packaging materials11%Direct labor7%Power/compressed air4%Waste/maintenance6%

Source: cost-structure assumption, 2026. Unit: share of variable cost.

Debt balance forecast
Debt balance forecast, USD thousand Y1686kY2515kY3343kY4172kY50k

Source: debt schedule, 2026. Unit: USD thousand.

35. Sources and Assumptions

Assumptions Register

Assumptions register
Assumption Value Basis Confidence Effect
Currency USD Analyst assumption Medium All outputs
Capacity 600 kg/h × 80% × 10 h/day × 300 days Calculated assumption Medium Revenue
Saleable output 1,440 t/y Calculated Medium Forecast
Selling price USD 2,500/t Planning assumption Low-medium Revenue and margin
Variable cost USD 1,650/t Parent rolls, packaging, labor, utilities and waste Medium Gross margin
Total investment $1.43m Budgetary machinery and factory allowance Medium NPV and funding
Financing 40% equity, 60% debt, 9%, five years Analyst assumption Low-medium Cash flow
Tax and discount 20% tax, 12% discount Planning assumption Low-medium NPV and net profit

Source Register

Source register
Ref Organization Source and URL Data used Access date Confidence
[1] World Bank World Development Indicators: Manufacturing, value added, https://api.worldbank.org/v2/indicator/NV.IND.MANF.CD Manufacturing context source 6 Aug 2026 High
[2] World Bank World Development Indicators: Population, total, https://api.worldbank.org/v2/indicator/SP.POP.TOTL Demand-localization context 6 Aug 2026 High
[3] USITC / HTS Chapter 48 paper and paperboard, https://hts.usitc.gov/reststop/file?release=currentRelease&filename=Chapter%2048 HS Chapter 48 classification caveat 6 Aug 2026 High for HS reference
[4] ISO ISO 12625 tissue paper and tissue products reference, https://www.iso.org/standard/72350.html Tissue standards context 6 Aug 2026 Medium-high; standard purchase may be required
[5] U.S. EPA Pulp and paper production air-pollution resources, https://www.epa.gov/stationary-sources-air-pollution Environmental context for paper industry 6 Aug 2026 Medium; more relevant to integrated mills
[6] OSHA Paper machine guarding eTool, https://www.osha.gov/etools/machine-guarding Machine guarding and safety context 6 Aug 2026 High for safety principles
[7] European Commission Waste Framework Directive, https://environment.ec.europa.eu/topics/waste-and-recycling/waste-framework-directive_en Waste-policy context 6 Aug 2026 High for EU context

36. Consultation Section

Need a Localized Tissue Paper Factory Study?

For a bankable tissue paper factory report, confirm country, city, jumbo-roll source, product mix, sheet counts, packaging design, utility tariff, building status, customer contracts, tax rate, financing terms and supplier quotations. Rolangear can support tissue converting line configuration, machinery selection, capacity planning and quote comparison.

Contact Rolangear

37. Final Conclusion and Recommendation

The tissue paper factory is technically feasible and financially positive under the stated budgetary assumptions. The investment is most attractive when the plant secures reliable jumbo-roll supply, maintains clean converting conditions, develops distributor and private-label channels, controls packaging cost and avoids excessive receivable exposure. The recommendation is to proceed to localized validation before final investment: confirm local demand, selling prices, parent-roll costs, product standards, packaging costs, building suitability, environmental and fire-safety requirements and formal supplier quotations.

Jack Doe

Hola, soy Jack, un ingeniero mecánico especializado en diseño mecánico patentado.

Leer más

PET Bottle Factory Feasibility Study
PET Bottle Factory

PET Bottle Factory Feasibility Study

Industrial Feasibility Study PET Bottle Factory Feasibility Study Professional feasibility study for a small-to-medium PET bottle factory producing water bottles, beverage bottles, edible-oil bo...

Leer más
Plastic Bag Factory Industrial-Feasibility-Study
Complete Guide to Plastic Bag Process

Plastic Bag Factory Industrial-Feasibility-Study

Industrial Feasibility Study Plastic Bag Factory Feasibility Study Professional feasibility study for a small-to-medium plastic bag factory producing T-shirt shopping bags, flat bags, garbage ba...

Leer más